| [1] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 20 12[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
|
| [2] |
NCCN.The NCCN non-small cell lung cancer clinical practice guidelines in oncology(version 2.2008)[EB/OL]. Fort Washington: NCCN. 2007 [2007-09-17]. http://www. nccn.org/ professionals/ physician gls/f_guidelines. asp.
|
| [3] |
Wu YL, Wang SY, Huang ZF, et al. Extent of lymphadenectomy in stageⅠ-ⅢA non-small cell lung cancer: a randomized clinical trial[J]. Zhonghua Zhong Liu Za Zhi, 2001, 23(1): 43-5. [吴一龙, 王思愚, 黄植蕃, 等. Ⅰ~ⅢA 期非小细胞肺癌淋巴结清扫范围 的前瞻性研究[J]. 中华肿瘤杂志, 2001, 23(1): 43-5.]
|
| [4] |
Wang SY, Wu YL, Rong TH, et al. Surgical treatment for stage Ⅲ N2 non-small cell lung cancer[J]. Zhonghua Zhong Liu Za Zhi, 20 02, 24(6): 605-7. [王思愚, 吴一龙, 戎铁华, 等. Ⅲ期N2非小细 胞肺癌的外科治疗[J]. 中华肿瘤杂志, 2002, 24(6): 605-7.]
|
| [5] |
Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial[J]. J Thorac Cardiovasc Surg, 2011, 141(3): 662-70.
|
| [6] |
Haigh PI, GiulianoAE. Sentinel lymph node dissection for thyroid malignancy[J]. Recent Results Cancer Res, 2000, 157: 201-5.
|
| [7] |
Su LF, Zhang SB, Zhu YM. Application of nano carbon tracer in sentinel lymph nodes of cN0 thyroid papillary carcinoma[J]. Zhongguo Xian Dai Yi Xue Za Zhi, 2013, 23(7): 110-2. [苏力夫, 张生彬, 朱永蒙. 纳米碳示踪前哨淋巴结在cN0甲状腺乳头状 癌中的应用[J]. 中国现代医学杂志, 2013, 23(7): 110-2.]
|
| [8] |
Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer[J]. Anesth Analg, 2002, 95(2): 385-8.
|
| [9] |
Yan J, Xue F, Chen H, et al. A multi-center study of using carbon nanoparticles to track lymph node metastasis in T1-2 colorectal cancer[J]. Surg Endosc, 2014, 28(12): 3315-21.
|
| [10] |
Yang F, Jin C, Yang D, et al. Magnetic functionalised carbonnanotubes as drug vehicles for cancer lymph node metastasis treatment[J]. Eur J Cancer, 2011, 47(12): 1873-82.
|
| [11] |
Ito T, Hagiwara A, Takagi T, et al. Local administration of methotrexate bound to activated carbon particles(MTX-CH) for treating cancers in mice[J]. Anticancer Res, 2003, 23(2B): 14 01-4.
|
| [12] |
van Tongeren MJ, Kromhout H, Gardiner K. Trends in levels of inhalable dust exposure, exceedance and overexposure in the European carbon black manufacturing industry[J]. Ann Occup Hyg, 2000, 44(4): 271-80.
|
| [13] |
Magrez A, Kasas S, Salicio V, et al. Cellular toxicity of carbonbased nanomaterials[J]. Nano Lett, 2006, 6(6): 1121-5.
|
| [14] |
Schroeder A, Heller DA, Winslow MM, et al. Treating metastatic cancer with nanotechnology[J]. Nat Rev Cancer, 2011, 12(1): 39-50.
|
| [15] |
Sun SP, Zhang Y, Cui ZQ, et al. Clinical application of carbon nanoparticle lymph node tracer in the VI region lymph node dissection of differentiated thyroid cancer[J]. Genet Mol Res, 20 14, 13(2): 3432-7.
|
| [16] |
Gong C, He ZG, Sun J. Research overviews of nanoparticles on the aspect of targeting lymphatic system[J]. Shenyang Yi Yao Da Xue Xue Bao, 2012, 29(6): 479-84. [龚成, 何仲贵, 孙进. 纳米 粒淋巴靶向的研究进展[J]. 沈阳药科大学学报, 2012, 29(6): 47 9-84.]
|
| [17] |
Li Z. Lymph node mapping in rabbit liver cancer with nanocarbon and methylene blue injecta[J]. Asian Pac J Trop Med, 2013, 6( 5):400-3.
|
| [18] |
Chen H, Huang GJ, Ni QX, et al. Distribution and migration of activated carbon in lymph nodes[J]. Xiao Hua Wai Ke Za Zhi, 20 06, 5(4): 288-90. [陈浩, 黄广建, 倪泉兴, 等. 活性炭在淋巴 结中的移行、分布规律研究[J]. 消化外科杂志, 2006, 5(4): 28 8-90.]
|
| [19] |
Liu J, Wong HL, Moselhy J, et al. Targeting colloidal particulates to thoracic lymph nodes[J]. Lung Cancer, 2006, 51(3): 377-86.
|
| [20] |
Li SB, He JX, Chen HZ, et al. Injection of activated carbon nanoparticles for guiding lymphadenectomy during minimal invasive surgery in lung cancer[J]. Zhonghua Zhong Liu Za Zhi, 20 08, 30(3): 228-30. [李树本, 何建行, 陈汉章, 等. 用纳米炭 在微创肺癌淋巴结清扫术中的研究[J]. 中华肿瘤杂志, 2008, 30 (3): 228-30.]
|
| [21] |
He J, Li S, Shao W, et al. Activated carbon nanoparticles or methylene blue as tracer during video-assisted thoracic surgery for lung cancer can help pathologist find the detected lymph nodes[J]. J Surg Oncol, 2010, 102(6): 676-82.
|
| [22] |
Yang Q, Wang XD, Chen J, et al. A clinical study on regional lymphatic chemotherapy using an activated carbon nanoparticleepirubicin in patients with breast cancer[J]. Tumour Biol, 2012, 33 (6): 2341-8.
|
| [23] |
Vaijayanthimala V, Cheng PY, Yeh SH, et al. The long-term stability and biocompatibility of fluorescent nanodiamond as an in vivo contrast agent[J]. Biomaterials, 2012, 33(31): 7794-802.
|
| [24] |
Sun ML, Xie WH, Wang CM, et al. Lymphatic targeting study of pingyangmycin-activated carbon nanoparticles treating oral cancer lymph nodemetastasis[J]. Huaxi Kou Qiang Yi Xue Za Zhi, 2011, 29 (3): 253-6, 263. [孙明磊, 谢卫红, 王昌美, 等. 平阳霉素-活性 炭纳米微粒行口腔癌淋巴化疗的靶向性评价[J]. 华西口腔医学 杂志, 2011, 29(3): 253-6, 263.]
|
| [25] |
Reuther T, Posselt NK, Rabbels J, et al. Oral squamous cell carcinoma retrospective analysis of therapy results and prognosis by neoadjuvant,preoperative radio-chemotherapy[J]. Mund Kiefer Gesichtschir, 2006, 10(1): 18-29.
|
| [26] |
Hagiwara A, Takahashi T, Ueda T, et al. Toxicity and pathological effects of a new dosage form of Mitomycin C for carcinomatous peritoneal[J]. Anticancer Res, 1987, 7(1): 105-8.
|
| [27] |
Chen H, Huang GJ, Ni QX, et al. The application of nanometric activated carbon particles in the intralymphatic chemotherapy as a drug carrier[J]. Fu Dan Xue Bao(Yi Xue Ban), 2007, 34(4): 51 8-21. [陈浩, 黄广建, 倪泉兴, 等. 纳米活性碳作为药物载体 在淋巴靶向治疗中的作用[J]. 复旦学报(医学版), 2007, 34(4): 51 8-21.]
|
| [28] |
Qian HR, Fan J, Liu YB, et al. Research for the treatment of paclitaxel-activated carbon particle delivery system in cancer lymph nodes metastasis[J]. Shi Yong Zhong Liu Za Zhi, 2006, 21 (2): 146-8. [钱浩然, 范健, 刘颖斌, 等. 活性炭吸附紫杉醇治 疗肿瘤淋巴结转移的实验研究[J]. 实用肿瘤杂志, 2006, 21 (2): 14 6-8.]
|
| [29] |
Bao CQ, Xu BH, Shen XM, et al. Application of activated carbon particles carring anticancer drug in radical operation of colon cancer[J]. Jiangsu Yi Yao, 2007, 33(10): 1004-5. [鲍传庆, 许炳华, 沈晓明, 等. 载药纳米碳在结肠癌手术中的应用[J]. 江苏医学, 20 07, 33(10): 1004-5.]
|
| [30] |
Wang XY, Zheng ZQ, Wang ZS, et al. A clinical observation of targeting treatment with adriamycin-activated carbon particle delivery system in human gastric carcinoma[J]. Zhejiang Yu Fang Yi Xue, 2003, 15(6): 21-3. [王向昱, 郑志强, 王增寿, 等. 活性炭 吸附阿霉素靶向治疗胃癌的临床观察[J]. 浙江预防医学, 2003, 15 (6): 21-3.]
|
| [31] |
Yang CW. Intrapleural injection of cisplatin-activated carbon particle delivery system in the treatment of cancerous pleural effusion[J]. Bengbu Yi Xue Yuan Xue Bao, 2003, 28(5): 429-30. [杨常菀. 活性炭吸附顺铂胸腔内注入治疗癌性胸腔积液[J]. 蚌 埠医学院学报, 2003, 28(5): 429-30.]
|
| [32] |
Sui XH, Zhou J, Meng R, et al. Intrapleural injection of arsenic trioxide-activated carbon particle delivery system in the treatment of cancerous pleural effusion[J]. Zhonghua Quan Ke Yi Shi Za Zhi, 2004, 3(5): 319-20. [隋新华, 周晋, 孟然, 等. 胸腔注入三氧 化二砷加活性炭治疗癌性胸水的临床研究[J]. 中华全科医师杂 志, 2004, 3(5): 319-20.]
|
下载:
